Sign in to view content

Safety of Intravitreal Pegcetacoplan for Geographic Atrophy: 12-Month Results of the OAKS and DERBY Trials

Caroline Baumal, MD, FASRS

Video
Published 2022

Related

Safety and Efficacy of Switching to Biosimilar Ranibizumab in Eyes Initially Treated With Reference Ranibizumab for nAMD, DME, or RVO
Nikhil K Bommakanti, MD
Annual Meeting Talks
2024
Efficacy of Intravitreal Pegcetacoplan in Geographic Atrophy: Results from the Phase 3 DERBY and OAKS Trials
Nathan C. Steinle, MD
Updates from the Field
2021
ARMD With Geographic Atrophy, Peripheral Degeneration
James B. Soque, CRA, OCT-C, COA, FOPS
Pamela Ann Weber, MD
Retina Image Bank: Images of the Week
2013

Category: AMD-Non-Neovascular

See more